Cingulate Inc. Common Stock (CING)
Stock · NASDAQ · Health Care
$4.38as of 10/16/2026
Price chart
Active signals
CING Signal Track Record
How signals performed across all stocks →What CING's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 26 | +0.2% | 50% | September 17, 2026 |
| Bollinger Band BreakdownActive now | 21 | +3.1% | 52% | September 25, 2026 |
| Bollinger Band Breakout | 19 | -14.4% | 16% | August 25, 2026 |
| 200-Day Moving Average TouchActive now | 9 | +0.8% | 56% | August 31, 2026 |
| Any 20-session window (baseline) | -4.5% | 41% |
Computed by MarketWall from daily closing prices since September 23, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About CING
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-210…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 14
- Website
- www.cingulate.com/
Fundamentals
- 1-day range
- $4.12$4.44
- Market cap
- $68.02M
- P/E (trailing)
- —
- P/E (forward)
- -4.95
- EPS (trailing)
- $-3.68
- Dividend yield
- —
- Beta
- -0.90
- Avg. volume
- 122.4K
Forecasts
5 analyst ratings
Cingulate Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- CINGCingulate Inc. Common Stock$4.36▼ 0.68%Market cap $68.02MP/E —$3.16$11.89
- CLNNClene Inc. Common Stock$3.1▼ 6.34%Market cap $68.24MP/E —$3.24$13.5
- RNTXRein Therapeutics Inc. Common Stock$0.59▼ 6.05%Market cap $67.45MP/E —$0.5401$2.18
- IBIOiBio Inc. Common Stock$0.77▼ 1.28%Market cap $69.05MP/E —$0.7328$3.82
- MNOVMedicinova Inc Common Stock$1.42▼ 2.07%Market cap $66.94MP/E —$1.17$3.9
- XBITXBiotech Inc. Common Stock$2.12▼ 1.85%Market cap $69.51MP/E —$2.09$3.44
- INOInovio Pharmaceuticals Inc. Common Stock$0.99▼ 4.81%Market cap $69.62MP/E —$0.5632$2.72
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CING Cingulate Inc. Common Stock | $68.02M | — | $4.36 | ▼ 0.68% | $3.16$11.89 |
| CLNN Clene Inc. Common Stock | $68.24M | — | $3.1 | ▼ 6.34% | $3.24$13.5 |
| RNTX Rein Therapeutics Inc. Common Stock | $67.45M | — | $0.59 | ▼ 6.05% | $0.5401$2.18 |
| IBIO iBio Inc. Common Stock | $69.05M | — | $0.77 | ▼ 1.28% | $0.7328$3.82 |
| MNOV Medicinova Inc Common Stock | $66.94M | — | $1.42 | ▼ 2.07% | $1.17$3.9 |
| XBIT XBiotech Inc. Common Stock | $69.51M | — | $2.12 | ▼ 1.85% | $2.09$3.44 |
| INO Inovio Pharmaceuticals Inc. Common Stock | $69.62M | — | $0.99 | ▼ 4.81% | $0.5632$2.72 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →- Raul R. Silva · September 30, 2026 · Grant4.3K
- Jennifer L. Callahan · July 16, 2026 · Grant19.8K
- Jennifer L. Callahan · July 16, 2026 · Grant40.2K
- Peter J. Werth · July 16, 2026 · Grant20.0K
- Raul R. Silva · July 16, 2026 · Grant26.4K
- Shane J. Schaffer · July 16, 2026 · Grant97.3K
- Shane J. Schaffer · July 16, 2026 · Grant197.7K
- Downey Bryan Wade · July 16, 2026 · Grant33.0K
- Downey Bryan Wade · July 16, 2026 · Grant67.0K
- Lawrence Bryan Jay · July 16, 2026 · Grant20.0K
- Matthew Brams · July 16, 2026 · Grant26.4K
- Matthew Brams · July 16, 2026 · Grant53.6K
- Thomas Jeffrey Hargroves · July 16, 2026 · Grant20.0K
- Raul R. Silva · July 16, 2026 · Grant53.6K
- Raul R. Silva · June 30, 2026 · Grant3.9K
Institutional Ownership
March 31, 2026
- Total shares held
- 1.13M
- Total value held
- $6.65M
- Institutional holders
- 25
- Unknown309.0K
- Unknown140.0K
- Unknown101.4K
- Unknown92.9K
- Unknown90.9K
- Unknown53.5K
- Unknown51.2K
- Unknown34.8K
- Unknown33.1K
- Unknown31.9K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
CING noted among health-care stocks with pre-market movement
CING was included in a Benzinga list of twelve health-care stocks that showed activity in the pre-market session on Tuesday. The mention suggests some early-day interest in the stock. The shares are currently near a support level of $5.03 and the RSI of 42.2 indicates modest momentum.
CING noted among health-care stocks with pre-market movement. CING was included in a Benzinga list of twelve health-care stocks that showed activity in the pre-market session on Tuesday. The mention suggests some early-day interest in the stock. The shares are currently near a support level of $5.03 and the RSI of 42.2 indicates modest momentum.